Among them, CYP3A5*3, the major member of the CYP450, apart from its significant role in exogenous carcinogens and the metabolism of drugs, is also implicated in the oxidation and inactivation of testosterone, and may therefore be associated with an increased risk of prostate cancer, particularly among African populations [60]. This evidence concerns the gene CYP3A5 and prostate carcinoma.